Development and validation of an enzyme-linked immunoassay kit for diagnosis and surveillance of COVID-19.
COVID-19
Diagnosis
ELISA
Prototyping
SARS-CoV-2
Serological assay
Journal
Journal of clinical virology plus
ISSN: 2667-0380
Titre abrégé: J Clin Virol Plus
Pays: England
ID NLM: 9918283581506676
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
received:
30
05
2022
revised:
12
07
2022
accepted:
16
07
2022
entrez:
12
8
2022
pubmed:
13
8
2022
medline:
13
8
2022
Statut:
ppublish
Résumé
There is a massive demand to identify alternative methods to detect new cases of COVID-19 as well as to investigate the epidemiology of the disease. In many countries, importation of commercial kits poses a significant impact on their testing capacity and increases the costs for the public health system. We have developed an ELISA to detect IgG antibodies against SARS-CoV-2 using a recombinant viral nucleocapsid (rN) protein expressed in
Identifiants
pubmed: 35959109
doi: 10.1016/j.jcvp.2022.100101
pii: S2667-0380(22)00040-0
pmc: PMC9356643
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100101Informations de copyright
© 2022 The Authors. Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest. Funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Références
MMWR Morb Mortal Wkly Rep. 2021 Dec 17;70(50):1731-1734
pubmed: 34914670
Nat Med. 2020 Jul;26(7):1033-1036
pubmed: 32398876
Stat Methods Med Res. 1999 Jun;8(2):135-60
pubmed: 10501650
Front Microbiol. 2014 Apr 17;5:172
pubmed: 24860555
Cell Rep. 2020 Jun 2;31(9):107725
pubmed: 32426212
Lancet. 2021 Feb 6;397(10273):452-455
pubmed: 33515491
EBioMedicine. 2021 Dec;74:103700
pubmed: 34861490
Viruses. 2020 Jul 07;12(7):
pubmed: 32646015
J Infect Dis. 2020 Jul 6;222(3):362-366
pubmed: 32473021
Emerg Infect Dis. 2020 Jul;26(7):1478-1488
pubmed: 32267220
Cell. 2021 Apr 1;184(7):1858-1864.e10
pubmed: 33631096
Emerg Microbes Infect. 2020 Dec;9(1):221-236
pubmed: 31987001
J Proteome Res. 2020 Apr 3;19(4):1351-1360
pubmed: 32200634
Sci Adv. 2022 May 13;8(19):eabn7424
pubmed: 35559681
J Virol Methods. 2005 May;125(2):181-6
pubmed: 15794988
Front Immunol. 2021 Nov 19;12:748291
pubmed: 34867975
Nat Med. 2020 Jun;26(6):845-848
pubmed: 32350462
Euro Surveill. 2020 Apr;25(16):
pubmed: 32347204
Nat Med. 2021 Jul;27(7):1230-1238
pubmed: 34035535
Braz J Infect Dis. 2020 Mar - Apr;24(2):180-187
pubmed: 32330437
J Mol Med (Berl). 2020 Jul;98(7):947-954
pubmed: 32535768
Lancet. 2004 Mar 13;363(9412):841-5
pubmed: 15031027
J Med Virol. 2005 Jun;76(2):137-42
pubmed: 15834868